FRE
FIREBRICK FPO [FRE]
Healthcare · ASX Small Cap
$0.0520 -3.7%
Updated 26 Mar 2026 · Scores refresh every scan
Score Breakdown
Technical21
Catalyst51
Sentiment50
Fundamental34
Momentum40
Risk Gate39
Get alerts when FRE's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI drifting toward oversold territory — worth watching
- Sitting right at the lower Bollinger Band — oversold and potentially ready to snap back
- Volume surging at 3.2x normal while price falls — heavy selling pressure
- Took a hit — down 11.9% over the last 5 days
- Low cash runway (3 quarters) - dilution risk
- Revenue in sharp decline (-53%)
- Near 52-week low (9% of range)
- Micro-cap ($5-20M) - high risk
- Sentiment is mixed — no strong consensus either way
- The bigger volume days are the up days — volume-weighted momentum is positive (0.50%/day)
- Altman Z-Score distress zone (1.42 < 1.81, low-confidence approx)
- Beneish M-Score 11.21 > -1.78: likely earnings manipulation
- RBA hiking (-3pts)
Risk Signals
- MACD crossed bearish — momentum is fading
- Trading below both moving averages — the trend is working against this one
- Broke below 20-day support — that's a level the market was defending, and it just gave way
- Below the 200-day average — the long-term trend is still working against it
- Piotroski F-Score weak (3/9, low-confidence approx)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Revenue declining at -53% — the top line is shrinking
- Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about FRE
3 free messages/day · Unlimited with Pro
Recent Catalysts
LOW Firebrick to present at NWR Virtual Healthcare Conference
NONE Nasodine patent accepted in the Philippines
NONE FRE appoints Head of Business Development and Licensing
NONE Firebrick Investor Update Presentation
Recent ASX Announcements
Key Metrics
$13.6M
Market Cap
42K
Avg Volume
3.2x
Vol Ratio
$0.05 — $0.09
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-142.7%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 51% |
| L | Leader vs Laggard | laggard | RS: -0 |
| I | Institutional Sponsorship | insufficient_data | Inst: 0% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #112 of 117 · Sector avg: 46
View all Healthcare signals →Track FRE and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required